Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merantix is a leading AI venture studio based in Berlin that conceptualizes, builds, and scales artificial intelligence companies across various industries, with a strong emphasis on healthcare and life sciences. The company operates the Merantix AI Campus, a hub for AI innovation, and has incubated several notable health-tech startups such as Vara, which focuses on AI-driven breast cancer screening, and Cambrium, a synthetic biology firm. By bridging the gap between academic research and commercial application, Merantix provides the technical infrastructure, funding, and talent necessary to develop transformative AI solutions. Their approach involves deep collaboration with industry partners and a focus on high-impact applications of machine learning in diagnostics and drug discovery. The studio model allows for rapid iteration and scaling of specialized AI products within the healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merantix.